1. Li, Ming, Yue, Weihua. 2018. VRK2, a Candidate Gene for Psychiatric and Neurological Disorders. In Molecular neuropsychiatry, 4, 119-133. doi:10.1159/000493941. https://pubmed.ncbi.nlm.nih.gov/30643786/
2. Shields, Julie A, Meier, Samuel R, Bandi, Madhavi, Huang, Alan, Emmanuel, Natasha. . VRK1 Is a Synthetic-Lethal Target in VRK2-Deficient Glioblastoma. In Cancer research, 82, 4044-4057. doi:10.1158/0008-5472.CAN-21-4443. https://pubmed.ncbi.nlm.nih.gov/36069976/
3. Tesli, Martin, Wirgenes, Katrine Verena, Hughes, Timothy, Djurovic, Srdjan, Andreassen, Ole A. 2016. VRK2 gene expression in schizophrenia, bipolar disorder and healthy controls. In The British journal of psychiatry : the journal of mental science, 209, 114-20. doi:10.1192/bjp.bp.115.161950. https://pubmed.ncbi.nlm.nih.gov/26941264/
4. He, Wen-Rui, Cao, Li-Bo, Yang, Yu-Lin, Hu, Ming-Ming, Shu, Hong-Bing. 2021. VRK2 is involved in the innate antiviral response by promoting mitostress-induced mtDNA release. In Cellular & molecular immunology, 18, 1186-1196. doi:10.1038/s41423-021-00673-0. https://pubmed.ncbi.nlm.nih.gov/33785841/
5. So, Jonathan, Mabe, Nathaniel W, Englinger, Bernhard, Filbin, Mariella G, Hahn, William C. 2022. VRK1 as a synthetic lethal target in VRK2 promoter-methylated cancers of the nervous system. In JCI insight, 7, . doi:10.1172/jci.insight.158755. https://pubmed.ncbi.nlm.nih.gov/36040810/
智鼠故事 
